Future Medical Diagnostic Manufacturers Co Ltd is categorized under in Fanwood, NJ and active since 2003.
Future Medical Diagnostic Manufacturers Co Ltd was established in 2003, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 423450 by the NAICS.
If you are seeking more information, feel free to contact Bob Khalil at the company’s single location by writing to 141 South Avenue, Fanwood, New Jersey NJ 07023 or by phoning (407) 888-0083. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Future Medical Diagnostic Manufacturers Co Ltd |
Contact Person: | Bob Khalil |
Address: | 141 South Avenue, Fanwood, New Jersey 07023 |
Phone Number: | (407) 888-0083 |
Website Address: | medsys.co.in |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2003 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | |
SIC Code: | 5047 |
NAICS Code: | 423450 |
Share This Business: |
Future Medical Diagnostic Manufacturers Co Ltd was started in 2003 to provide professional under the SIC code 5047 and NAICS code 423450. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Bob Khalil for inquiries that concern Future Medical Diagnostic Manufacturers Co Ltd by calling the company number (407) 888-0083, as your correspondence is most welcome. Additionally, the physical location of the single location of Future Medical Diagnostic Manufacturers Co Ltd can be found at the coordinates 40.638339,-74.387367 as well as the street address 141 South Avenue in Fanwood, New Jersey 07023.
For its online presence, you may visit Future Medical Diagnostic Manufacturers Co Ltd’s website at medsys.co.in and engage with its social media outlets through on Twitter and on Facebook.